Search tickers (stock/ETF/mutual fund)...

600161.SS

Beijing Tiantan Biological Products Corp Ltd

Price:

18.99

CNY

Volume:

8,691,872

China | Biotechnology

Valuation Overview Financials Forecast Compare Historical Price Dividends Transactions People

No data available for this ticker

600161.SS Probability of Bankruptcy

The Probability of Bankruptcy of Beijing Tiantan Biological Products Corp Ltd (600161.SS) is 0% . This number represents the probability that 600161.SS will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating 600161.SS's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

600161.SS - Historical Solvency Measures

Drag here to set row groups

Drag here to set column labels

2023-12-31

2022-12-31

2021-12-31

2020-12-31

2019-12-31

2018-12-31

2017-12-31

2016-12-31

2015-12-31

2014-12-31

2013-12-31

Cash & ST Investments

Long-term Debts

Total Debt

Free Cash Flow

Net Debt / Equity

Quick Ratio

Net Debt / Assets

Altman Z-score

FCF / Debt

0.95

0.56

0.67

1.92

1.25

1.41

1.75

3.32

0.68

2.19

2.83

1.04

1.78

1.91

0.2

0.23

0.4

0.47

0.37

1.46

0.25

2.67

2.36

2.44

0.53

0.26

0.41

0.81

0.52

2.23

0.43

0.16

0.01

0.17

0.22

-0.08

0.38

0.12

0.09

-0.15

0.02

-0.23

1.32

0.88

0.93

0.76

0.38

0.29

0.26

0.21

0.35

0.81

0.2

0.27

0.49

0.56

0.8

3.72

3.52

3.18

2.62

6.64

0.57

4.25

3.66

0.29

0.32

0.3

0.26

0.19

0.16

0.12

0.24

0.28

0.14

0.19

6.82

7.58

7.88

18.34

17.07

12.72

10.27

8.85

7.68

7.71

7.51

0.01

0.07

0.09

-0.15

1.47

0.29

0.11

-0.29

0.01

-0.53

8.15

to of Page of

600161.SS - ESG ratings

ESG ratings are directly linked to the cost of capital and 600161.SS's ability to raise funding, both of which can significantly affect the probability of Beijing Tiantan Biological Products Corp Ltd going bankrupt.

ESG Score

39.58

Environment Score

53.23

Social Score

37.41

Governance Score

28.1

Returns

Historical Returns (5 day)	0.38%
Historical Returns (MTD)	-2.37%
Historical Returns (YTD)	-18.62%
Historical Returns (13 week)	0.38%
Historical Returns (26 week)	-18.68%
Historical Returns (52 week)	30.58%

Efficiency

Asset Turnover	0.36
Receiveable Turnover	222.8

Gross Margin	54.2%
Operating Margin	39.9%
Pretax Margin	39.8%
Net Margin	24.4%

Return on Asset (ROA)	8.65
Return on Equity (ROE)	12.73
Return on Investments (ROI)	12.52

Price Metrics

Market Cap (M)	37,550.3
Enterprise Value (M)	36,201.3

52 Week High	27.6
52 Week Low	20.17
Beta	1.12
Average Volume (10 day)	12.12
Average Volume (3 month)	15.88

Price / Earnings (P/E)	31.8
Price / Sales (P/S)	7.7

Earnings

EPS	0.64
Revenue CAGR (5 year)	12.06%

Risk

Current Ratio	5.22
Quick Ratio	3.2

600161.SS - Peer Comparisons

Ticker	Company Name	Beta	Probability of Bankruptcy
a
KROS	Keros Therapeutics Inc	1	8.7%
PRTA	Prothena Corporation PLC	0.83	9%
YMAB	Y-mAbs Therapeutics, Inc	1.57	45.7%